Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Novartis Investigative Site, Lima

Novartis Investigative Site, Brussels

Novartis Investigative Site, Liège

Novartis Investigative Site, Prague

Novartis Investigative Site, Madrid

Private Practice, Jacksonville

Novartis Investigative Site, Valencia

Novartis Investigative Site, Münster

Novartis Investigative Site, Tartu

Texas Derm and Laser Specialists ., San Antonio

First OC Dermatology, Fountain Valley

Novartis Investigative Site, Moscow

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Krasnodar

Novartis Investigative Site, Kazan'

Novartis Investigative Site, Lebanon

Novartis Investigative Site, Hradec Králové

Novartis Investigative Site, Dresden

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Rzeszów

Novartis Investigative Site, Wroclaw

Novartis Investigative Site, Esplugues de Llobregat

Novartis Investigative Site, Sabadell